BR9815745A - Combinações de inibidor de metaloproteinase de matriz estatina - Google Patents
Combinações de inibidor de metaloproteinase de matriz estatinaInfo
- Publication number
- BR9815745A BR9815745A BR9815745-0A BR9815745A BR9815745A BR 9815745 A BR9815745 A BR 9815745A BR 9815745 A BR9815745 A BR 9815745A BR 9815745 A BR9815745 A BR 9815745A
- Authority
- BR
- Brazil
- Prior art keywords
- statin
- combinations
- matrix metalloproteinase
- metalloproteinase inhibitor
- inhibitor
- Prior art date
Links
- 229940121710 HMGCoA reductase inhibitor Drugs 0.000 title abstract 2
- 229940121386 matrix metalloproteinase inhibitor Drugs 0.000 title 1
- 239000003771 matrix metalloproteinase inhibitor Substances 0.000 title 1
- 229940124761 MMP inhibitor Drugs 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
- 239000011159 matrix material Substances 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- DFVFTMTWCUHJBL-BQBZGAKWSA-N statine Chemical compound CC(C)C[C@H](N)[C@@H](O)CC(O)=O DFVFTMTWCUHJBL-BQBZGAKWSA-N 0.000 abstract 1
- 208000019553 vascular disease Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Diabetes (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US7826598P | 1998-03-17 | 1998-03-17 | |
| PCT/US1998/024681 WO1999047138A1 (en) | 1998-03-17 | 1998-11-20 | Statin-matrix metalloproteinase inhibitor combinations |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR9815745A true BR9815745A (pt) | 2000-11-14 |
Family
ID=22142950
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR9815745-0A BR9815745A (pt) | 1998-03-17 | 1998-11-20 | Combinações de inibidor de metaloproteinase de matriz estatina |
Country Status (18)
| Country | Link |
|---|---|
| EP (1) | EP1063991A1 (enExample) |
| JP (1) | JP2002506818A (enExample) |
| KR (1) | KR20010041916A (enExample) |
| AR (1) | AR018113A1 (enExample) |
| AU (1) | AU1591699A (enExample) |
| BR (1) | BR9815745A (enExample) |
| CA (1) | CA2309588A1 (enExample) |
| CO (1) | CO5070670A1 (enExample) |
| GT (1) | GT199900039A (enExample) |
| HN (1) | HN1999000029A (enExample) |
| MY (1) | MY140504A (enExample) |
| NZ (1) | NZ505994A (enExample) |
| PA (1) | PA8469001A1 (enExample) |
| PE (1) | PE20000348A1 (enExample) |
| SV (1) | SV1999000026A (enExample) |
| UY (1) | UY25436A1 (enExample) |
| WO (1) | WO1999047138A1 (enExample) |
| ZA (1) | ZA992106B (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FI94339C (fi) | 1989-07-21 | 1995-08-25 | Warner Lambert Co | Menetelmä farmaseuttisesti käyttökelpoisen /R-(R*,R*)/-2-(4-fluorifenyyli)- , -dihydroksi-5-(1-metyylietyyli)-3-fenyyli-4-/(fenyyliamino)karbonyyli/-1H-pyrroli-1-heptaanihapon ja sen farmaseuttisesti hyväksyttävien suolojen valmistamiseksi |
| GB0100761D0 (en) | 2001-01-11 | 2001-02-21 | Biocompatibles Ltd | Drug delivery from stents |
| AU2005315608B2 (en) | 2004-12-15 | 2011-03-31 | Solvay Pharmaceuticals Gmbh | Pharmaceutical compositions comprising NEP-inhibitors, inhibitors of the endogenous endothelin producing system and HMG CoA reductase inhibitors |
| KR101329112B1 (ko) * | 2005-11-08 | 2013-11-14 | 랜박시 래보러터리스 리미티드 | (3ｒ,5ｒ)-7-〔2-(4-플루오로페닐)-5-이소프로필-3-페닐-4-〔(4-히드록시 메틸 페닐 아미노)카르보닐〕-피롤-1-일〕-3,5-디히드록시 헵탄산 헤미 칼슘염의 제조 방법 |
| WO2010005389A1 (en) * | 2008-07-11 | 2010-01-14 | Forskarpatent I Syd Ab | Oxidized ldl specific antibody-fusion and conjugated proteins |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1217656C (zh) * | 1995-11-02 | 2005-09-07 | 沃尼尔·朗伯公司 | 用于调节脂浓度的方法和药物组合物 |
| EP0901466B1 (en) * | 1996-05-17 | 2001-10-31 | Warner-Lambert Company | Biphenylsulfonamide matrix metalloproteinase inhibitors |
| NZ334897A (en) * | 1996-12-09 | 2001-02-23 | Warner Lambert Co | Medicaments for treating and preventing heart failure and ventricular dilatation |
| TW536540B (en) * | 1997-01-30 | 2003-06-11 | Bristol Myers Squibb Co | Endothelin antagonists: N-[[2'-[[(4,5-dimethyl-3-isoxazolyl)amino]sulfonyl]-4-(2-oxazolyl)[1,1'-biphenyl]-2-yl]methyl]-N,3,3-trimethylbutanamide and N-(4,5-dimethyl-3-isoxazolyl)-2'-[(3,3-dimethyl-2-oxo-1-pyrrolidinyl)methyl]-4'-(2-oxazolyl)[1,1'-biphe |
| GT199800126A (es) * | 1997-08-29 | 2000-01-29 | Terapia de combinacion. |
-
1998
- 1998-11-20 KR KR1020007010223A patent/KR20010041916A/ko not_active Ceased
- 1998-11-20 EP EP98960279A patent/EP1063991A1/en not_active Withdrawn
- 1998-11-20 JP JP2000536378A patent/JP2002506818A/ja active Pending
- 1998-11-20 WO PCT/US1998/024681 patent/WO1999047138A1/en not_active Ceased
- 1998-11-20 AU AU15916/99A patent/AU1591699A/en not_active Abandoned
- 1998-11-20 NZ NZ505994A patent/NZ505994A/xx unknown
- 1998-11-20 BR BR9815745-0A patent/BR9815745A/pt not_active Application Discontinuation
- 1998-11-20 CA CA002309588A patent/CA2309588A1/en not_active Abandoned
-
1999
- 1999-02-24 AR ARP990100751A patent/AR018113A1/es unknown
- 1999-03-15 MY MYPI99000951A patent/MY140504A/en unknown
- 1999-03-16 CO CO99016109A patent/CO5070670A1/es unknown
- 1999-03-16 GT GT199900039A patent/GT199900039A/es unknown
- 1999-03-16 ZA ZA9902106A patent/ZA992106B/xx unknown
- 1999-03-16 UY UY25436A patent/UY25436A1/es not_active Application Discontinuation
- 1999-03-16 PA PA19998469001A patent/PA8469001A1/es unknown
- 1999-03-16 HN HN1999000029A patent/HN1999000029A/es unknown
- 1999-03-16 SV SV1999000026A patent/SV1999000026A/es not_active Application Discontinuation
- 1999-03-16 PE PE1999000217A patent/PE20000348A1/es not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| CA2309588A1 (en) | 1999-09-23 |
| EP1063991A1 (en) | 2001-01-03 |
| AR018113A1 (es) | 2001-10-31 |
| CO5070670A1 (es) | 2001-08-28 |
| JP2002506818A (ja) | 2002-03-05 |
| NZ505994A (en) | 2003-10-31 |
| PE20000348A1 (es) | 2000-05-22 |
| HN1999000029A (es) | 1999-09-29 |
| AU1591699A (en) | 1999-10-11 |
| WO1999047138A1 (en) | 1999-09-23 |
| SV1999000026A (es) | 2000-01-18 |
| KR20010041916A (ko) | 2001-05-25 |
| GT199900039A (es) | 2000-09-06 |
| UY25436A1 (es) | 2001-10-25 |
| MY140504A (en) | 2009-12-31 |
| PA8469001A1 (es) | 2002-09-17 |
| ZA992106B (en) | 1999-09-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR0113669A (pt) | Inibidores da desacetilase | |
| BR9805544A (pt) | Uso de um composto. | |
| BR0212014A (pt) | Uso de derivados do ácido hidroxâmico inibidores da enzima histone deacetilase | |
| PA8506101A1 (es) | Uso de un compuesto acat para fabricar una composicion farmaceutica | |
| FI940012A0 (fi) | Aryylisulfonamidosubstituoidut hydroksaamihapot | |
| BR9812753A (pt) | Combinação farmacêutica, uso da mesma, processo para tratamento de uma doença inflamatória, e, composição farmacêutica | |
| MA26812A1 (fr) | Pyrimidine-2,4,6-triones inhibitrices de metalloproteinases | |
| BR0317715A (pt) | Composições e processos de uso de collajolie | |
| ATE266000T1 (de) | Hydroxamsäure- und carbonsäure-derivate mit mmp und tnf hemmender wirkung | |
| BR9807655A (pt) | Uso de inibidores de lipase gastrintestinal. | |
| BR9711194A (pt) | Uso de agente quelante clioquinol para a fabricação de uma composição farmacêutica para o tratamento de doença de alzheimer. | |
| NO973035D0 (no) | Hydroksaminsyre-holdige inhibitorer for matriks-metallproteaser | |
| EE200000093A (et) | Agrekanaasi ja maatriksmetalloproteinaaside uudsed inhibiitorid artriidi käitlemiseks | |
| BR9812371A (pt) | Tratamento de distúrbio de conduta | |
| ATE266634T1 (de) | Cyclobutyl-aryloxysulfonylamin- hydroxamsäurederivate | |
| BR9812357A (pt) | Tratamento de distúbio oposicional desafiador | |
| FR2834890B1 (fr) | Composition pharmaceutique orodispersible d'agomelatine | |
| BR9714142A (pt) | Uso de inibidores de metaloproteìnases matriciais para tratamento de distúrbios neurológicos e promoção de cicatrização de feridas | |
| EA200401183A1 (ru) | Применение ингибиторов il-18 в качестве диагностического маркера | |
| BR0112212A (pt) | Uma combinação de inibidores de fbpase e agentes antidiabéticos úteis para o tratamento de diabetes | |
| DE60330180D1 (de) | Kosmetische zusammensetzung enthaltend ein siegesbeckia extrakt und ein lipopeptid | |
| BR9713207A (pt) | Derivados de 3-mercaptoacetilamino-1,5-substituìdo-2-oxo-azepan uteis como inibidores de metaloproteinase de matriz | |
| SE9801494D0 (sv) | Novel use | |
| BR9910678A (pt) | Composto, composição farmacêutica, método para traramento ou prevenção de uma doença inflamatória, método para tratamento de uma condição ou uma doença mediada por mmps, tnf, agrecanase, ou um composto dos mesmos, em um mamìfero, método de redução de nìveis de tnf em pacientes, sem a inibição de mmps, método para tratamento de uma condição ou uma doença e uso de um novo composto | |
| IS5951A (is) | 5HT1 mótlyf fyrir meðferð gegn þunglyndi |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
| B15K | Others concerning applications: alteration of classification |
Free format text: ALTERADA DE INT.CL: A61K 45/06, A61P 9/10 Ipc: A61K 31/40 (2008.04) |
|
| B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: INDEFIRO O PRESENTE PEDIDO DE PATENTE DE ACORDO COM ART. 8O DA LPI. |
|
| B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL. |